Ujjivan Small Finance Bank Seeks ₹409 Crore Share Approval

Ujjivan Small Finance Bank Limited will seek shareholder approval on November 13, 2026, for a preferential issue of up to 6,31,91,619 equity shares that could raise ₹409.04 crore at ₹64.73 per share. The proposed capital raise is intended to strengthen the bank's capital adequacy and support its stated growth plans.

What will Ujjivan SFB shareholders consider at the EGM?

Ujjivan SFB shareholders will consider a special resolution to issue equity shares through a preferential private placement at an Extraordinary General Meeting scheduled for 3:30 p.m. IST on November 13, 2026. The meeting will be conducted through video conferencing or other audio-visual means.

The proposal covers up to 6,31,91,619 equity shares with a face value of ₹10 each. The issue price is ₹64.73 per share, comprising a ₹10 face value and a premium of ₹54.73. At the maximum proposed number of shares, the consideration is ₹4,09,03,93,497.87, or approximately ₹409.04 crore.

The board approved the proposed preferential issue at its meeting on October 16, 2026. The issue remains subject to shareholder approval at the EGM, as well as the applicable regulatory and stock exchange processes before allotment.

The notice for the EGM was dispatched on October 19, 2026. Shareholders eligible to vote remotely could cast their votes from 9:00 a.m. on November 10 until 5:00 p.m. on November 12, 2026.

Who are the proposed investors in Ujjivan SFB's share issue?

The proposed allottees are International Finance Corporation, Bajaj Life Insurance Limited, Aditya Birla Sun Life Insurance Company Limited, and HDFC Life Insurance Company Limited. The placement is structured as a private placement to qualified institutional buyers.

International Finance Corporation is specifically identified among the proposed investors in the bank's disclosures. The other proposed allottees are domestic insurance companies, and the supplied information does not state the individual number of shares or amount proposed to be subscribed by each investor.

The bank has said the capital infusion is aimed at bolstering capital adequacy and supporting strategic growth ambitions. No separate allocation among the four proposed allottees has been disclosed in the available information.

The relevant date for determining the minimum issue price was October 14, 2026, which was 30 days before the scheduled EGM. The proposed price was therefore fixed with reference to that stated date under the preferential-issue process.

How could the preferential issue affect Ujjivan SFB's capital position?

The preferential issue, if approved and allotted in full, would bring up to ₹409.04 crore of fresh equity capital into Ujjivan SFB. The bank has explicitly linked the proposal to strengthening capital adequacy, which is a key measure of a bank's capacity to absorb losses while supporting lending and other operations.

Fresh equity also increases the number of outstanding shares. Existing shareholders would therefore own a smaller proportion of the bank after a full allotment unless they participate in a manner that maintains their ownership, although the supplied information does not quantify the resulting dilution.

For investors, the principal disclosed terms are the maximum number of shares, the ₹64.73 issue price and the institutional investor group proposed to receive the shares. The proposal does not provide a post-issue shareholding pattern, capital adequacy ratio, or financial projections, so the direct numerical effect on these measures cannot be calculated from the available disclosures.

The bank has also stated that it will not use the issue proceeds until filing e-Form PAS-3 with the Registrar of Companies. This filing is part of the corporate compliance process associated with the allotment of securities.

What other equity-linked approvals has Ujjivan SFB disclosed?

Ujjivan SFB disclosed separate employee equity-linked approvals on October 16, 2026. Its Nomination and Remuneration Committee approved 1,32,77,429 options under the Bank ESOP Scheme 2019 and 2,44,111 options under the RSU Plan 2026.

Each vested option under these plans confers the right to one fully paid equity share, according to the disclosed terms. The ESOP exercise price was stated as ₹64, while the RSU approval is identified as being under the RSU Plan 2026.

These employee-plan approvals are distinct from the proposed ₹409.04 crore preferential issue. The preferential issue requires the shareholder resolution being considered at the EGM, whereas the employee equity awards were approved by the Nomination and Remuneration Committee as disclosed.

Conclusion

Ujjivan SFB has placed a ₹409.04 crore preferential equity proposal before shareholders, involving up to 6,31,91,619 shares at ₹64.73 each. The proposed institutional placement is intended to strengthen capital adequacy, while also creating potential dilution for existing shareholders through the increase in equity share capital.

The immediate item to watch is the shareholder vote at the November 13 EGM. If the resolution is approved, the next disclosed procedural steps include the required regulatory and stock exchange processes, allotment of shares, and filing of e-Form PAS-3 before the bank uses the proceeds.